Dietary Compounds Drive Epigenetic Regulation and Modifications in Blood Cancer: A Critical Review
Common dietary compounds show promise modulating cancer-related genes in laboratory studies, though safe clinical doses remain unclear.
This review summarizes how dietary phytochemicals (curcumin, resveratrol, quercetin, EGCG) modulate epigenetic mechanisms including DNA methylation and histone modifications in blood cancers. Clinical translation is limited by bioavailability challenges and lack of clinical trial validation.
What the study was
- Study design
- Critical review
- Population
- Blood cancer patients and preclinical models
- Category
- Prevention
- Maturity
- Exploratory
- Journal
- Molecular Nutrition & Food Research
Why it surfaced
Review only; no clinical validation data for dietary epigenetics in blood cancers.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.